|
 |
|
|||||||
|
|||||||||
Correspondence to:
Tetsurou Handa.
Lipoprotein lipase (LPL) hydrolyzes triacylglycerol (TG) of TG -rich lipoproteins. We investigated the effects of sphingomyelin (SM) and cholesterol (Chol) on the lipolysis of lipid emulsions by LPL using human apolipoprotein C-II (apoC-II) or plasma as an activator. Kinetic studies of the lipolysis rates clearly demonstrated that the primary effect of the activator on the LPL reaction was not to increase the affinity of LPL for the emulsion surface, but to enhance LPL catalytic activity. Incorporation of SM into the emulsion surface caused increases in Km(app) and decreases in Vmax(app), indicating that SM inhibited lipolysis by decreasing both affinity for substrates and catalytic activity of LPL. SM was also found to affect possible factors related to the lipolysis rates; that is, SM increased TG solubility in surface layers and decreased apoC-II binding to the emulsion surface. Interestingly, Chol did not affect the lipolysis rates even though it decreased TG solubility and apoC-II binding. These results indicated that neither TG solubility nor amount of apoC-II binding were determinate factors in LPL-mediated lipolysis under physiological conditions.
Our results suggest that the content of SM in the lipoprotein surface plays an important role by controlling lipoprotein lipase-mediated lipolysis, and that cholesterol enrichment in the lipoprotein surface has no influence on lipolysis, but may affect other metabolic processes such as uptake by the liver through the selectivity of apolipoprotein binding.—Arimoto, I., H. Saito, Y. Kawashima, K . Miyajima, and T. Handa. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J. Lipid Res. 1998. 39: 143–151.
Supplementary key words:
lipoprotein lipase, lipolysis, lipid emulsions, sphingomyelin, cholesterol, apolipoprotein C-II
Copyright © 1998 by Lipid Research, Inc.
Original Article
Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions
Itaru Arimotoa,
Hiroyuki Saitob,
Yasuko Kawashimaa,
Koichiro Miyajimaa, and
Tetsurou Handaa
a Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-01, Japan
b Division of Drugs, National Institute of Health Sciences, 1-1-43 Hoenzaka, Chuoh-ku, Osaka 540, Japan
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. K. Singh and P. V. Subbaiah Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids J. Lipid Res., March 1, 2007; 48(3): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Subbaiah, L. R. Gesquiere, and K. Wang Regulation of the selective uptake of cholesteryl esters from high density lipoproteins by sphingomyelin J. Lipid Res., December 1, 2005; 46(12): 2699 - 2705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-S. Park, R. L. Panek, S. B. Mueller, J. C. Hanselman, W. S. Rosebury, A. W. Robertson, E. K. Kindt, R. Homan, S. K. Karathanasis, and M. D. Rekhter Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E-Knockout Mice Circulation, November 30, 2004; 110(22): 3465 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Subbaiah, V. S. Subramanian, and K. Wang Novel Physiological Function of Sphingomyelin in Plasma. INHIBITION OF LIPID PEROXIDATION IN LOW DENSITY LIPOPROTEINS J. Biol. Chem., December 17, 1999; 274(51): 36409 - 36414. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |